In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

HIV targets and destroys these CD4 + T cells—key players in the immune response—weakening the body's ability to fight infections and certain cancers. Antiretroviral therapy ...

Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...

On the one hand, it became clear that CD4 + T-cell depletion, the hallmark of HIV disease, was caused not simply by destruction of late-stage CD4 + T effector cells but also by the host's ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...